AS
Simona, Aurélien
Affiliation entities
Research groups
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| QT prolongation alerts lead to monitoring but rarely to therapeutic changes : a prospective hospital study | Frontiers in pharmacology | 2026 | 6 | 12 | |||
| Stimulant drugs and stimulant use disorder | Anesthesiology clinics | 2024 | 70 | 0 | |||
| A genome-wide Association study of the Count of Codeine prescriptions | Scientific reports | 2024 | 4 | 13 | |||
| Polygenic risk scores in pharmacogenomics : opportunities and challenges-a mini review | Frontiers in genetics | 2023 | 111 | 152 | |||
| Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review | The Lancet. Digital health | 2022 | 154 | 397 | |||
| Intelligent Telehealth in Pharmacovigilance: A Future Perspective | Drug safety | 2022 | 185 | 330 | |||
| The Swiss Cheese Prescribing Model for Precision Medicine | American Journal of Medicine | 2020 | 313 | 276 | |||
| Stratification du risque basée sur les biomarqueurs dans l'embolie pulmonaire non massive chez les patients âgés d'au moins 65 ans | 2020 | 549 | 559 | ||||
| High-sensitive cardiac troponin T as a marker of hemorrhagic complications in elderly patients anticoagulated for non-massive pulmonary embolism | Thrombosis Research | 2019 | 374 | 0 | |||
| Comparison of Cardiac and Non-Cardiac Biomarkers for Risk Stratification in Elderly Patients with Non-Massive Pulmonary Embolism | PloS one | 2016 | 794 | 344 |
